sorafenib has been researched along with icaritin in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (icaritin) | Trials (icaritin) | Recent Studies (post-2010) (icaritin) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 202 | 1 | 178 |
| Protein | Taxonomy | sorafenib (IC50) | icaritin (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 2.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, W; Luo, C; Ma, L; Man, S; Yan, M; Zhao, G | 1 |
1 review(s) available for sorafenib and icaritin
| Article | Year |
|---|---|
Treatment for liver cancer: From sorafenib to natural products.
Topics: Antineoplastic Agents; Biological Products; Flavonoids; Ginsenosides; Humans; Immediate-Early Proteins; Liver Neoplasms; Neoplastic Stem Cells; Protein Serine-Threonine Kinases; Resveratrol; Sorafenib | 2021 |